Invest in your expertise

MedTech Syndicates is open to both practicing and retired clinicians. Joining is simple, just provide your basic details and choose one of our membership programs to begin your investment journey and gain access to exclusive early-stage MedTech opportunities.

MedTech Syndicates works with

• Class I to Class III medical devices

• In Vitro Devices (IVD) Class A to D

• Digital health projections

MedTech Syndicates (MTS) gives clinicians, whether practicing or retired—access to early-stage investment opportunities in medical technology, digital health, and diagnostics. The platform is designed to make investing in MedTech companies compliant, transparent, and clinically led.

• Joining MedTech Syndicates

  Clinicians sign up to become members of MTS. Membership is open to licensed clinicians worldwide and includes access to our investment platform, webinars, and educational resources on how to invest responsibly in early-stage MedTech.

• Discover Curated Opportunities

  MTS sources and screens companies solving real clinical problems. Each company is evaluated by our advisory team and independent Key Opinion Leaders (KOLs) before being listed on the platform. Only technologies that pass our due-diligence and regulatory checks are presented to members.

• Participate in Pitch Panels

  Clinicians are invited to exclusive Pitch Panel Webinars, where company CEOs and clinical champions present their solutions. Members can ask questions, review due-diligence documents, and hear from other clinician investors before deciding to invest.

• Invest Through Secure Compliant Structures

  Once you decide to invest, MTS provides a regulated pathway under U.S. SEC-compliant exemptions (Reg CF, Reg D 506(c), Reg A+, or Reg S for international investors).
  All transactions are handled through our broker-dealer (ICON Capital) and compliance partner (KORE), ensuring your investment is fully legal and documented.

• Track and Manage Your Investments

  After investing, your MTS dashboard allows you to:

• View your portfolio and share certificates

• Access company updates, reports, and future rounds

• Join follow-on SPVs for additional funding opportunities

• Grow with the Network

  Members can take on larger roles—such as becoming a Regional Clinical Officer (RCO) or KOL Advisor—helping identify new innovations, lead diligence in their specialty, and earn sweat-equity shares for contributions.

Yes. MedTech Syndicates operates on a monthly membership model. However, clinicians are given a free trial period to explore the platform, review live investment opportunities, and experience how MedTech Syndicates works. After this period, you can decide whether you’d like to continue as an active member.

MedTech Syndicates is uniquely built for clinicians. Unlike generic crowdfunding sites, every opportunity is curated, clinically validated, and structured to comply with SEC and FINRA regulations.
Key advantages for clinicians:

• Rigorous Due Diligence: All opportunities undergo compliance and “Testing the Waters” validation before being publicly marketed—ensuring the legitimacy of the offering and the quality of the science.

• SEC-Compliant General Solicitation: You can safely review and invest in publicly marketed opportunities, knowing each raise meets strict legal standards under Reg CF or Reg D 506(c).

• Clinician-Led Validation: Fellow clinicians help assess the unmet clinical need, usability, and potential impact—bridging the gap between frontline medicine and investment insight.

• Educational Support: Access investment education, pitch webinars, and due diligence overviews tailored to busy healthcare professionals.

Traditional funds pool capital from investors (limited partners or “LPs”) who have little say in which companies receive funding. Decisions are made by fund managers, and LPs may wait years for liquidity without direct visibility into progress. MedTech Syndicates offers a transparent and flexible model designed for clinicians who want both access and control.
Key differences:

• Direct Choice: Choose which companies to invest in based on your expertise and conviction.

• Lower Minimums: Participate with smaller ticket sizes instead of committing large sums to a blind-pool fund.

• Transparency: Gain direct visibility into companies, teams, and milestones.

• Engagement: Participate as an investor, advisor, or KOL to help shape innovations.

• Diversification: Build your own portfolio across specialities or technologies.

• Liquidity: Reg CF and Reg A+ allow for earlier liquidity options, unlike typical 7–10-year fund lockups.
  In short, MedTech Syndicates empowers clinicians to invest intelligently, selectively, and compliantly—combining professional insight with flexibility and control.

Yes. Under Reg CF, Reg A+ and Reg D 506(c), general solicitation (public marketing of investment opportunities) is fully permitted—provided that Reg CF offerings are conducted through FINRA-registered portals, and Reg D 506(c) offerings verify that all investors are accredited.

Yes. Under Reg CF, both accredited and non-accredited clinicians can invest, subject to annual limits based on income and net worth. Under Reg D 506(c), only accredited clinicians may invest after verification. Under Reg A+, both accredited and non-accredited investors can participate in SEC-qualified offerings.

You can still invest under Reg CF and Reg A+, which are designed to democratize access. The minimum investment is $10,000 dollars.

For Reg D 506(c) offerings, accredited status is verified through tax returns or W-2s showing qualifying income, or a CPA, attorney, or broker letter confirming your status.

Reg CF: Securities are locked for one year, after which transfers are typically allowed. Reg A+: Up to 30% of a raise can be structured as a liquidity event (secondary sale), allowing early investors to sell part of their holdings.

As a member, you gain access to webinars hosted by clinicians and MedTech experts, deep-dive investment briefings and timestamped replays, and tutorials on due diligence, CAP tables, and risk factors.